Cargando…
Cancer patients with potential eligibility for vascular endothelial growth factor antagonists use have an increased risk for cardiovascular diseases comorbidities
BACKGROUND: Recent studies have reported the prevalence of cardiovascular diseases (CVDs) among cancer patients following the use of the vascular endothelial growth factor (VEGF) signaling inhibitors. However, data for patients with a history of cancer before active cancer treatment are lacking. Thi...
Autores principales: | Liu, Fei, Hidru, Tesfaldet H., Gao, Ruiyuan, Lin, Yajuan, Liu, Ying, Fang, Fengqi, Liu, Jiwei, Li, Huihua, Yang, Xiaolei, Xia, Yunlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012358/ https://www.ncbi.nlm.nih.gov/pubmed/31584518 http://dx.doi.org/10.1097/HJH.0000000000002277 |
Ejemplares similares
-
Postmenopausal Women with Breast, Endometrial, and Ovarian Cancers Have an Increased Risk for Cardiovascular Conditions prior to Active Endocrine Therapy
por: Han, Xu, et al.
Publicado: (2022) -
Does Serum Uric Acid Status Influence the Association Between Left Atrium Diameter and Atrial Fibrillation in Hypertension Patients?
por: Hidru, Tesfaldet H., et al.
Publicado: (2020) -
Reply
por: Liu, Fei, et al.
Publicado: (2021) -
The Relationship Between Serum Uric Acid at Different Concentrations of Lipid Indices and the Risk of Myocardial Revascularization in Patients With Acute Coronary Syndrome: A Retrospective Analysis
por: Lin, Yajuan, et al.
Publicado: (2021) -
Sinus node dysfunction and stroke risk: a systematic review and meta-analysis
por: Dong, Haoyu, et al.
Publicado: (2023)